GeneSight(R) shown to statistically significantly improve generalized anxiety disorder
Assurex Health, a Myriad Genetics subsidiary, announced new positive results for the GeneSight® test in patients with Generalized Anxiety Disorder. The study found that GeneSight guided treatment statistically significantly improved treatment response in patients with GAD. October 19, 2017